EBITDA

NetSuite introduces new AI-powered SuiteCloud Agent Skills, promising faster, more secure development and leveraging open standards to redefine ERP agility.

SENS is set to showcase its PowerCab2, a factory-built system challenging how data centers and utilities ensure 'always-on' power and reliability.

Kadence's new SpaceOps platform uses a custom AI and live usage data to transform how enterprises design and manage their hybrid workplaces.

While the world chases AI, one entrepreneur argues real wealth is made with a pressure washer. His new book makes the case for hands-on, tangible business.

Breach Secure Now's new program helps MSPs turn the hidden danger of unmanaged AI in small businesses into a secure, strategic advantage in 90 days.

A Silicon Valley firm's new patent could end reactive cybersecurity by translating raw data into meaningful, predictive intelligence for AI systems.

Forrester's latest report crowns Temenos a leader, highlighting its advanced architecture as a key strategy for banks in the competitive, AI-driven era.

The mattress maker sees showroom growth, but a revenue miss, widening losses, and a 'going concern' warning signal a tough road ahead for the company.

Venture capital firm Altira cashes out on a major energy tech success, as simulation leader ResFrac secures new funding to expand into geothermal energy.

In a strategic move, Cloudstate buys Gen Z community Girlhood, aiming to build a unique ecosystem that prioritizes emotional safety over social comparison.

Ascidian Therapeutics to present first human safety data for its Stargardt disease drug, a new RNA editing technology with broad potential for genetic diseases.

As fire incidents in battery and renewable sites grow, a new integrated system aims to prevent disasters by combining proactive sensing with rapid suppression.

Sweco reports stable Q1 growth amid a divided European market, leaning on infrastructure projects and key acquisitions to offset real estate sector weakness.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

Encoded Therapeutics is set to unveil pivotal data on ETX101, a one-time gene therapy showing promise in not just stopping seizures but reversing developmental delays.

Dyno Therapeutics is using AI to design 'smart' viral vectors, promising safer, more effective treatments for untreatable genetic diseases.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.

Proptech giant SmartRent is moving beyond large complexes, launching a new program to bring smart home technology to millions of smaller rental properties.

The blank check company extends its merger deadline after an $850k sponsor deposit, facing a new owner, a cautious market, and a Nasdaq compliance notice.